Zimmer Biomet (ZBH) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Zimmer Biomet Revenue Highlights


Latest Revenue (Y)

$1.94B

Latest Revenue (Q)

$143.40M

Main Segment (Y)

Knees

Main Geography (Y)

Americas

Zimmer Biomet Revenue by Period


Zimmer Biomet Revenue by Year

DateRevenueChange
2023-12-31$1.94B-72.04%
2022-12-31$6.94B1.65%
2021-12-31$6.83B-2.81%
2020-12-31$7.02B-12.00%
2019-12-31$7.98B0.62%
2018-12-31$7.93B1.39%
2017-12-31$7.82B1.82%
2016-12-31$7.68B28.11%
2015-12-31$6.00B28.34%
2014-12-31$4.67B1.08%
2013-12-31$4.62B3.39%
2012-12-31$4.47B0.45%
2011-12-31$4.45B5.49%
2010-12-31$4.22B3.05%
2009-12-31$4.10B-0.62%
2008-12-31$4.12B5.74%
2007-12-31$3.90B11.50%
2006-12-31$3.50B6.37%
2005-12-31$3.29B10.24%
2004-12-31$2.98B56.81%
2003-12-31$1.90B38.52%
2002-12-31$1.37B16.44%
2001-12-31$1.18B13.26%
2000-12-31$1.04B10.82%
1999-12-31$939.00M9.06%
1998-12-31$861.00M-

Zimmer Biomet generated $1.94B in revenue during NA 2023, up -72.04% compared to the previous quarter, and up 24.46% compared to the same period a year ago.

Zimmer Biomet Revenue by Quarter

DateRevenueChange
2024-09-30$143.40M-92.62%
2024-06-30$1.94B2.79%
2024-03-31$1.89B-2.62%
2023-12-31$1.94B10.64%
2023-09-30$1.75B-6.20%
2023-06-30$1.87B2.11%
2023-03-31$1.83B0.32%
2022-12-31$1.83B9.30%
2022-09-30$1.67B-6.29%
2022-06-30$1.78B7.13%
2022-03-31$1.66B-6.41%
2021-12-31$1.78B-7.63%
2021-09-30$1.92B-5.08%
2021-06-30$2.03B9.72%
2021-03-31$1.85B-11.41%
2020-12-31$2.09B8.09%
2020-09-30$1.93B57.35%
2020-06-30$1.23B-31.26%
2020-03-31$1.78B-16.08%
2019-12-31$2.13B12.33%
2019-09-30$1.89B-4.84%
2019-06-30$1.99B0.66%
2019-03-31$1.98B-4.61%
2018-12-31$2.07B12.76%
2018-09-30$1.84B-8.51%
2018-06-30$2.01B-0.50%
2018-03-31$2.02B-2.73%
2017-12-31$2.07B14.09%
2017-09-30$1.82B-6.97%
2017-06-30$1.95B-1.16%
2017-03-31$1.98B-1.78%
2016-12-31$2.01B9.84%
2016-09-30$1.83B-5.23%
2016-06-30$1.93B1.58%
2016-03-31$1.90B-1.53%
2015-12-31$1.93B9.73%
2015-09-30$1.76B50.92%
2015-06-30$1.17B2.93%
2015-03-31$1.13B-7.24%
2014-12-31$1.22B10.57%
2014-09-30$1.11B-6.50%
2014-06-30$1.18B1.84%
2014-03-31$1.16B-6.38%
2013-12-31$1.24B15.49%
2013-09-30$1.07B-8.14%
2013-06-30$1.17B2.69%
2013-03-31$1.14B-3.52%
2012-12-31$1.18B15.11%
2012-09-30$1.03B-8.84%
2012-06-30$1.13B-1.38%
2012-03-31$1.14B-2.28%
2011-12-31$1.17B13.17%
2011-09-30$1.03B-9.31%
2011-06-30$1.14B1.95%
2011-03-31$1.12B-1.68%
2010-12-31$1.13B17.59%
2010-09-30$965.00M-8.76%
2010-06-30$1.06B-0.48%
2010-03-31$1.06B-4.02%
2009-12-31$1.11B13.50%
2009-09-30$975.60M-4.34%
2009-06-30$1.02B2.75%
2009-03-31$992.60M-3.65%
2008-12-31$1.03B8.19%
2008-09-30$952.20M-11.79%
2008-06-30$1.08B1.92%
2008-03-31$1.06B-

Zimmer Biomet generated $143.40M in revenue during Q3 2024, up -92.62% compared to the previous quarter, and up 7.67% compared to the same period a year ago.

Zimmer Biomet Revenue Breakdown


Zimmer Biomet Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Hips$1.97B$1.89B$1.86B$1.75B$1.94B
Other Product Category$636.00M$570.00M$595.60M$518.50M$280.00M
S E T$1.75B$1.70B$1.73B$1.32B$1.80B
Knees$3.04B$2.78B$2.65B$2.39B$2.81B
Dental And Spine--$1.01B--
Dental Spine And C M F T---$1.04B-
Dental----$414.00M
Spine And C M F----$747.30M

Zimmer Biomet's latest annual revenue breakdown by segment (product or service), as of Dec 23: Knees (41.09%), Hips (26.60%), S E T (23.70%), and Other Product Category (8.60%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Knees$745.10M$788.10M$798.20M$706.30M$771.40M$762.50M$753.60M$657.00M$704.90M$662.80M$720.10M$647.90M$665.60M$614.30M$737.10M$648.70M$374.20M$629.80M$760.60M$651.90M
Other Product Category$143.40M$157.30M$183.70M$158.80M$151.20M$142.30M$158.70M$135.40M$143.30M$132.60M$165.90M$146.10M$161.10M$122.50M$154.20M$141.10M$87.10M$136.10M$74.00M$67.10M
S E T$454.20M$452.60M$453.30M$423.20M$442.70M$433.40M$424.10M$409.40M$446.40M$416.80M$410.50M$437.60M$462.10M$417.60M$375.90M$359.90M$252.60M$333.60M$473.70M$437.70M
Hips$481.50M$491.20M$504.80M$465.30M$504.30M$492.80M$488.70M$468.00M$487.20M$451.00M$480.70M$453.80M$474.60M$447.00M$504.10M$484.10M$329.70M$432.60M$511.30M$460.20M
Dental And Spine----------$260.70M$238.60M$263.50M$246.00M------
Dental Spine And C M F T--------------$314.00M$295.50M$182.50M$251.70M--
Spine And C M F------------------$197.30M$181.30M
Dental------------------$108.80M$94.20M

Zimmer Biomet's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Knees (40.85%), Hips (26.40%), S E T (24.90%), and Other Product Category (7.86%).

Zimmer Biomet Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
Asia Pacific$1.18B$1.19B$1.36B$1.30B$1.36B
EMEA$1.59B$1.46B---
Americas$4.62B$4.30B$4.80B$4.34B$4.88B
E M E A--$1.67B$1.39B$1.75B
Americas Spine And Global Dental--$882.00M--
Americas And Global Businesses---$4.48B-
UNITED STATES---$4.12B-

Zimmer Biomet's latest annual revenue breakdown by geography, as of Dec 23: Americas (62.54%), EMEA (21.54%), and Asia Pacific (15.93%).

Quarterly Revenue by Country

CountrySep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Americas$1.14B$1.19B$1.21B$1.11B$1.16B$1.14B$1.05B$1.09B$1.00B$1.27B$1.11B$1.28B$733.70M$1.29B$1.18B-----
Asia Pacific$312.00M$258.00M$301.00M$302.10M$310.50M$264.10M$294.20M$305.40M$309.20M$279.00M$308.80M$350.40M$357.50M$348.20M$393.10M$346.60M$273.70M$284.40M$367.10M$338.60M
E M E A$376.20M$444.80M$426.00M$379.90M$379.90M$464.00M$393.10M$429.80M$384.20M$408.30M$366.20M$218.70M$398.10M$470.40M$374.60M-----
EMEA--$426.00M$337.90M$402.90M$425.60M$377.50M$319.30M------------
Americas Orthopedics-----------$1.01B$1.06B-------
Americas Spine And Global Dental-----------$208.50M$230.00M-------
Americas And Global Businesses--------------$1.33B$1.25B$1.14B---

Zimmer Biomet's latest quarterly revenue breakdown by geography, as of Sep 24: Americas (62.27%), E M E A (20.62%), and Asia Pacific (17.10%).

Zimmer Biomet Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
BIOBio-Rad Laboratories$2.67T$649.73M
ABTAbbott Laboratories$40.11B$10.63B
MDTMedtronic$32.36B$7.92B
SYKStryker$20.50B$5.49B
EWEdwards Lifesciences$6.00B$1.39B
BRKRBruker$2.96B$800.70M
ZBHZimmer Biomet$1.94B$143.40M
ITGRInteger$1.60B$746.27M
CNMDCONMED$1.24B$316.70M
GKOSGlaukos$314.71M$95.69M
SRDXSurmodics$132.58M$30.34M
LUNGPulmonx$68.67M$20.39M
CVRXCVRx$39.30M$13.37M
OFIXOrthofix Medical$100.00K$198.62M

ZBH Revenue FAQ


Zimmer Biomet's yearly revenue for 2023 was $1.94B, representing a decrease of -72.04% compared to 2022. The company's yearly revenue for 2022 was $6.94B, representing an increase of 1.65% compared to 2021. ZBH's yearly revenue for 2021 was $6.83B, representing a decrease of -2.81% compared to 2020.

Zimmer Biomet's quarterly revenue for Q3 2024 was $143.4M, a -92.62% decrease from the previous quarter (Q2 2024), and a -91.82% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $1.94B, a 2.79% increase from the previous quarter (Q1 2024), and a 3.87% increase year-over-year (Q2 2023). ZBH's quarterly revenue for Q1 2024 was $1.89B, a -2.62% decrease from the previous quarter (Q4 2023), and a 3.18% increase year-over-year (Q1 2023).

Zimmer Biomet's revenue growth rate for the last 3 years (2021-2023) was -71.58%, and for the last 5 years (2019-2023) was -75.69%.

Zimmer Biomet's revenue streams in c 23 are Hips, Other Product Category, S E T, and Knees. Hips generated $1.97B in revenue, accounting 26.60% of the company's total revenue, up 3.82% year-over-year. Other Product Category generated $636M in revenue, accounting 8.60% of the company's total revenue, up 11.58% year-over-year. S E T generated $1.75B in revenue, accounting 23.70% of the company's total revenue, up 3.29% year-over-year. Knees generated $3.04B in revenue, accounting 41.09% of the company's total revenue, up 9.36% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of Zimmer Biomet was Knees. This segment made a revenue of $3.04B, representing 41.09% of the company's total revenue.